[{"NetIncomeLoss_1_Q1_USD":-15764000.0,"ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions_1_Q1_USD":106000.0,"OperatingLeaseLiability_0_Q1_USD":3172000.0,"PreferredStockSharesOutstanding_0_Q1_shares":1016000.0,"MarketableSecuritiesCurrent_0_Q1_USD":186718000.0,"DepreciationAndAmortization_1_Q1_USD":196000.0,"GeneralAndAdministrativeExpense_1_Q1_USD":4109000.0,"WeightedAverageNumberOfShareOutstandingBasicAndDiluted_1_Q1_shares":36824619.0,"CommitmentsAndContingencies_0_Q1_USD":null,"Liabilities_0_Q1_USD":14394000.0,"AccumulatedOtherComprehensiveIncomeLossNetOfTax_0_Q1_USD":-990000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross_1_Q1_shares":1111950.0,"AccountsPayableAndAccruedLiabilitiesCurrent_0_Q1_USD":7580000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearThree_0_Q1_USD":576000.0,"AssetsCurrent_0_Q1_USD":283260000.0,"StockIssuedDuringPeriodValueStockOptionsExercised_1_Q1_USD":106000.0,"LesseeOperatingLeaseLiabilityPaymentsDueYearTwo_0_Q1_USD":576000.0,"CommonStockSharesIssued_0_Q1_shares":40962715.0,"Assets_0_Q1_USD":290671000.0,"NetCashProvidedByUsedInInvestingActivities_1_Q1_USD":-55104000.0,"ShareBasedCompensation_1_Q1_USD":1965000.0,"AdditionalPaidInCapitalCommonStock_0_Q1_USD":65457000.0,"CashAndCashEquivalentsAtCarryingValue_0_Q1_USD":87985000.0,"ResearchAndDevelopmentExpense_1_Q1_USD":16308000.0,"InterestIncomeDepositsWithFinancialInstitutions_1_Q1_USD":651000.0,"LesseeOperatingLeaseLiabilityPaymentsDue_0_Q1_USD":3914000.0,"EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents_1_Q1_USD":67000.0,"AccountsReceivableNetCurrent_0_Q1_USD":5060000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate_1_Q1_pure":0.68,"IncomeTaxExpenseBenefit_1_Q1_USD":-68000.0,"CommonStockValue_0_Q1_USD":498334000.0,"OperatingLeaseLiabilityNoncurrent_0_Q1_USD":2902000.0,"IncreaseDecreaseInAccountsPayableAndAccruedLiabilities_1_Q1_USD":-3213000.0,"ForeignCurrencyTransactionGainLossBeforeTax_1_Q1_USD":155000.0,"ForeignCurrencyTransactionGainLossUnrealized_1_Q1_USD":204000.0,"NetCashProvidedByUsedInFinancingActivities_1_Q1_USD":118721000.0,"AdjustmentsToAdditionalPaidInCapitalShareBasedCompensationStockOptionsRequisiteServicePeriodRecognition_1_Q1_USD":1965000.0,"CommonStockNoParValue_0_Q1_USD":null,"ProceedsFromSaleAndMaturityOfMarketableSecurities_1_Q1_USD":45955000.0,"NetIncomeLossAvailableToCommonStockholdersBasic_1_Q1_USD":-15341000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate_1_Q1_pure":0.0115,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod_1_Q1_shares":5936.0,"OperatingLeaseRightOfUseAsset_0_Q1_USD":3206000.0,"DeferredIncomeTaxAssetsNet_0_Q1_USD":514000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue_1_Q1_USD":12.86,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect_1_Q1_USD":42976000.0,"IncreaseDecreaseInAccountsReceivable_1_Q1_USD":3238000.0,"CommonStockSharesOutstanding_0_Q1_shares":40962715.0,"PaymentsToAcquireMarketableSecurities_1_Q1_USD":100655000.0,"IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest_1_Q1_USD":-15832000.0,"MarketableSecuritiesUnrealizedGainLoss_1_Q1_USD":-74000.0,"NetCashProvidedByUsedInOperatingActivities_1_Q1_USD":-20708000.0,"LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths_0_Q1_USD":703000.0,"RetainedEarningsAccumulatedDeficit_0_Q1_USD":-294256000.0,"LiabilitiesCurrent_0_Q1_USD":11492000.0,"OtherAccruedLiabilitiesCurrent_0_Q1_USD":82000.0,"OperatingLeaseWeightedAverageDiscountRatePercent_0_Q1_pure":0.0245,"PreferredStockNoParValue_0_Q1_USD":null,"CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsIncludingDisposalGroupAndDiscontinuedOperations_0_Q1_USD":87985000.0,"StockIssuedDuringPeriodSharesStockOptionsExercised_1_Q1_shares":122403.0,"OperatingLeasePayments_1_Q1_USD":202000.0,"PreferredStockSharesIssued_0_Q1_shares":1016000.0,"PropertyPlantAndEquipmentNet_0_Q1_USD":3691000.0,"PrepaidExpenseAndOtherAssetsCurrent_0_Q1_USD":3497000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber_0_Q1_shares":2769438.0,"VariableLeaseCost_1_Q1_USD":184000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber_0_Q1_shares":5742608.0,"LesseeOperatingLeaseLiabilityUndiscountedExcessAmount_0_Q1_USD":268000.0,"IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets_1_Q1_USD":533000.0,"OperatingIncomeLoss_1_Q1_USD":-16059000.0,"AccountsPayableTradeCurrent_0_Q1_USD":2132000.0,"InvestmentIncomeInterest_1_Q1_USD":72000.0,"ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate_1_Q1_pure":0.0,"ContractWithCustomerLiabilityCurrent_0_Q1_USD":3642000.0,"PreferredStockValue_0_Q1_USD":7732000.0,"DeferredIncomeTaxExpenseBenefit_1_Q1_USD":9000.0,"OperatingLeaseCost_1_Q1_USD":139000.0,"LiabilitiesAndStockholdersEquity_0_Q1_USD":290671000.0,"EmployeeRelatedLiabilitiesCurrent_0_Q1_USD":1323000.0,"OperatingLeaseLiabilityCurrent_0_Q1_USD":270000.0,"OperatingExpenses_1_Q1_USD":20417000.0,"EarningsPerShareBasicAndDiluted_1_Q1_USD":-0.42,"ProfitLoss_1_Q1_USD":-15764000.0,"StockholdersEquity_0_Q1_USD":276277000.0,"PaymentsToAcquirePropertyPlantAndEquipment_1_Q1_USD":404000.0,"RevenueFromContractWithCustomerIncludingAssessedTax_1_Q1_USD":4358000.0,"LesseeOperatingLeaseLiabilityPaymentsRemainderOfFiscalYear_0_Q1_USD":618000.0,"AccruedProfessionalFeesCurrent_0_Q1_USD":289000.0,"Ticker":"XENE","CIK":"1582313","name":"XENON PHARMACEUTICALS INC.","OfficialName":"Xenon Pharmaceuticals Inc. Common Shares","form":"10-Q","period":"20210331","fy":"2021.0","fp":"Q1","qtrs":"1","uom":"USD","footnote":"nan","Market Cap":"1764405075.0","Country":"Canada","Sector":"nan","Industry":"nan","Market":"NASDAQ","SP500":"nan","filed":"20210511"}]